October 18, 2020
Article
New data show patients hospitalized with COVID-19 far more frequently suffer from cardiometabolic disease, yet face worse outcomes with COPD.
October 24, 2019
A new study shows that bronchoscopy practice, procedure, and tools vary by facility, and in assessment duration.
October 23, 2019
From medical marijuana to vape devices, there seems to be a divide in defining what's legal for use, and what's actually beneficial for users.
How the LAMA therapy manages one of the integral facets of COPD care.
While one disease is benefitting from advancing digital screening measures, the other has a standard therapy which could provide benefit to both.
October 22, 2019
How should physicians navigate the public belief that vaping is less harmful than cigarette smoking?
How the aclidinium bromide trial brings novel perspective to COPD care.
Are diagnostics and drugs optimized for pulmonary hypertension?
October 21, 2019
New ASCENT-COPD data show the therapy's benefit in reducing cardiovascular events among high-risk patients, along with significant exacerbation reduction.
What the introduction of aclidinium/formoterol could mean for patients with COPD.
Patients With Vitiligo Report Varied Severe Symptoms Based on Skin Tone
Ruxolitinib Beneficial Across Demographics of Patients with Vitiligo
Promising Data from InPedILD Phase 3 Trial Revealed at ERS Congress 2022
